# GD Culture Group Ltd: financial statements, quarterly

GDC · Nasdaq · CIK 1641398 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gdc.md) · [Financials](/companies/gdc/financials.md) · [Filings](/companies/gdc/filings.md) · [Insiders](/companies/gdc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gdc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [(0.1) d](/filings/0001213900-23-088602.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [0.0 d](/filings/0001213900-24-098486.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | [0.2](/filings/0001213900-25-044218.md) | [0.2](/filings/0001213900-25-074991.md) | [0.2](/filings/0001213900-25-104943.md) | [0.1 d](/filings/0001213900-26-035630.md) | not reported | [0.2](/filings/0001213900-26-090150.md) | [1.2](/filings/0001213900-25-104943.md) | [0.8 d](/filings/0001213900-26-035630.md) | [0.3](/filings/0001213900-26-042579.md) | [0.6](/filings/0001213900-26-090150.md) |
| Selling, general and administrative | $m | [1.6](/filings/0001213900-24-098486.md) | [3.4 d](/filings/0001013762-24-000473.md) | [1.8](/filings/0001213900-24-045188.md) | [1.7](/filings/0001213900-24-069008.md) | [0.9](/filings/0001213900-24-098486.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(1.6)](/filings/0001213900-24-098486.md) | [(10.3) d](/filings/0001213900-25-024635.md) | [(4.2)](/filings/0001213900-25-044218.md) | [(3.6)](/filings/0001213900-25-074991.md) | [(3.9)](/filings/0001213900-25-104943.md) | [(2.5) d](/filings/0001213900-26-035630.md) | [(0.9)](/filings/0001213900-26-042579.md) | [(1.6)](/filings/0001213900-26-090150.md) | [(2.5)](/filings/0001213900-25-104943.md) | [(3.5) d](/filings/0001213900-26-035630.md) | [(1.6)](/filings/0001213900-26-042579.md) | [(2.8)](/filings/0001213900-26-090150.md) |
| Interest expense | $m | [0.0](/filings/0001213900-23-088602.md) | [0.0 d](/filings/0001013762-24-000473.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | [0.0](/filings/0001213900-25-044218.md) | [(0.0)](/filings/0001213900-25-074991.md) | [(0.0)](/filings/0001213900-25-104943.md) | [(0.0) d](/filings/0001213900-26-035630.md) | [0.0](/filings/0001213900-26-042579.md) | [(0.1)](/filings/0001213900-26-090150.md) | [1.7](/filings/0001213900-25-104943.md) | [(1.7) d](/filings/0001213900-26-035630.md) | [0.0](/filings/0001213900-26-042579.md) | [(0.0)](/filings/0001213900-26-090150.md) |
| Net income | $m | [(3.4)](/filings/0001213900-24-098486.md) | [(8.9) d](/filings/0001213900-25-024635.md) | [(4.0)](/filings/0001213900-25-044218.md) | [(3.6)](/filings/0001213900-25-074991.md) | [(3.7)](/filings/0001213900-25-104943.md) | [(2.5) d](/filings/0001213900-26-035630.md) | [(1.0)](/filings/0001213900-26-042579.md) | [(1.5)](/filings/0001213900-26-090150.md) | [12.1](/filings/0001213900-25-104943.md) | [(196) d](/filings/0001213900-26-035630.md) | [(164)](/filings/0001213900-26-042579.md) | [(52.2)](/filings/0001213900-26-090150.md) |
| Diluted EPS | $ per share | [(1.12)](/filings/0001213900-24-098486.md) | not reported | [(0.56)](/filings/0001213900-25-044218.md) | [(0.39)](/filings/0001213900-25-074991.md) | [(0.36)](/filings/0001213900-25-104943.md) | not reported | [(0.08)](/filings/0001213900-26-042579.md) | [(19.00)](/filings/0001213900-26-090150.md) | [0.48](/filings/0001213900-25-104943.md) | not reported | [(2.53)](/filings/0001213900-26-042579.md) | [(53.40)](/filings/0001213900-26-090150.md) |
| Basic EPS | $ per share | [(1.12)](/filings/0001213900-24-098486.md) | not reported | [(0.56)](/filings/0001213900-25-044218.md) | [(0.39)](/filings/0001213900-25-074991.md) | [(0.36)](/filings/0001213900-25-104943.md) | not reported | [(0.08)](/filings/0001213900-26-042579.md) | [(19.00)](/filings/0001213900-26-090150.md) | [0.48](/filings/0001213900-25-104943.md) | not reported | [(2.53)](/filings/0001213900-26-042579.md) | [(53.40)](/filings/0001213900-26-090150.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.6](/filings/0001213900-23-088602.md) | [5.2](/filings/0001213900-25-024635.md) | [0.5](/filings/0001213900-24-045188.md) | [0.3](/filings/0001213900-24-069008.md) | [0.0](/filings/0001213900-24-098486.md) | [0.0](/filings/0001213900-26-035630.md) | [0.1](/filings/0001213900-25-044218.md) | [1.1](/filings/0001213900-25-074991.md) | [0.2](/filings/0001213900-25-104943.md) | [0.5](/filings/0001213900-26-090150.md) | [0.0](/filings/0001213900-26-042579.md) | [7.2](/filings/0001213900-26-090150.md) |
| Current assets | $m | [6.6](/filings/0001213900-23-088602.md) | [9.1](/filings/0001213900-25-024635.md) | [6.1](/filings/0001213900-24-045188.md) | [2.6](/filings/0001213900-24-069008.md) | [2.0](/filings/0001213900-24-098486.md) | [0.0](/filings/0001213900-26-035630.md) | [0.1](/filings/0001213900-25-044218.md) | [2.5](/filings/0001213900-25-074991.md) | [0.6](/filings/0001213900-25-104943.md) | [0.8](/filings/0001213900-26-090150.md) | [0.2](/filings/0001213900-26-042579.md) | [37.8](/filings/0001213900-26-090150.md) |
| Total assets | $m | [13.9](/filings/0001213900-23-088602.md) | [14.2](/filings/0001213900-25-024635.md) | [11.1](/filings/0001213900-24-045188.md) | [8.5](/filings/0001213900-24-069008.md) | [4.8](/filings/0001213900-24-098486.md) | [2.7](/filings/0001213900-26-035630.md) | [2.6](/filings/0001213900-25-044218.md) | [10.6](/filings/0001213900-25-074991.md) | [866](/filings/0001213900-25-104943.md) | [670](/filings/0001213900-26-090150.md) | [507](/filings/0001213900-26-042579.md) | [500](/filings/0001213900-26-090150.md) |
| Current liabilities | $m | [0.3](/filings/0001213900-23-088602.md) | [0.4](/filings/0001213900-25-024635.md) | [0.5](/filings/0001213900-24-045188.md) | [0.5](/filings/0001213900-24-069008.md) | [0.7](/filings/0001213900-24-098486.md) | [1.5](/filings/0001213900-26-035630.md) | [1.6](/filings/0001213900-25-044218.md) | [1.1](/filings/0001213900-25-074991.md) | [3.0](/filings/0001213900-25-104943.md) | [1.2](/filings/0001213900-26-090150.md) | [1.9](/filings/0001213900-26-042579.md) | [1.2](/filings/0001213900-26-090150.md) |
| Total liabilities | $m | [1.7](/filings/0001213900-23-088602.md) | [2.0](/filings/0001213900-25-024635.md) | [2.2](/filings/0001213900-24-045188.md) | [2.0](/filings/0001213900-24-069008.md) | [2.2](/filings/0001213900-24-098486.md) | [2.7](/filings/0001213900-26-035630.md) | [2.7](/filings/0001213900-25-044218.md) | [2.0](/filings/0001213900-25-074991.md) | [3.8](/filings/0001213900-25-104943.md) | [2.0](/filings/0001213900-26-090150.md) | [2.6](/filings/0001213900-26-042579.md) | [1.9](/filings/0001213900-26-090150.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [6.8](/filings/0001213900-23-088602.md) | [8.3](/filings/0001213900-25-024635.md) | [8.5](/filings/0001213900-24-045188.md) | [6.0](/filings/0001213900-24-069008.md) | [2.3](/filings/0001213900-24-098486.md) | [(0.3)](/filings/0001213900-26-035630.md) | [(0.3)](/filings/0001213900-25-044218.md) | [8.3](/filings/0001213900-25-074991.md) | [862](/filings/0001213900-25-104943.md) | [668](/filings/0001213900-26-090150.md) | [504](/filings/0001213900-26-042579.md) | [498](/filings/0001213900-26-090150.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.8) d](/filings/0001213900-24-098486.md) | [(6.8) d](/filings/0001213900-25-024635.md) | [(3.6)](/filings/0001213900-25-044218.md) | [(1.4) d](/filings/0001213900-25-074991.md) | [(0.3) d](/filings/0001213900-25-104943.md) | [(0.4) d](/filings/0001213900-26-035630.md) | [(0.8)](/filings/0001213900-26-042579.md) | [(2.9) d](/filings/0001213900-26-090150.md) | [(0.9) d](/filings/0001213900-25-104943.md) | [(2.2) d](/filings/0001213900-26-035630.md) | [(0.6)](/filings/0001213900-26-042579.md) | [(11.7) d](/filings/0001213900-26-090150.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001213900-24-098486.md) | [0.0 d](/filings/0001213900-25-024635.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1.4](/filings/0001213900-23-088602.md) | [1.8](/filings/0001213900-24-045188.md) | [2.5](/filings/0001213900-24-069008.md) | [3.1](/filings/0001213900-24-098486.md) | [7.4](/filings/0001213900-25-044218.md) | [9.3](/filings/0001213900-25-074991.md) | [10.5](/filings/0001213900-25-104943.md) | [11.5](/filings/0001213900-26-042579.md) | [0.1](/filings/0001213900-26-090150.md) | [25.2](/filings/0001213900-25-104943.md) | [64.8](/filings/0001213900-26-042579.md) | [1.0](/filings/0001213900-26-090150.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,162,500 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-090150.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.